Life Imaging FLA is a Florida based preventive screening provider that focuses on heart and full body imaging for adults. Founded in Deerfield Beach in 2020, it now operates multiple locations and positions its services as an accessible early detection option for heart disease and cancer.
Background and organizational history
Life Imaging FLA was established in Deerfield Beach, Florida, in 2020. The company was founded by Tom Graham, whose decision to focus on prevention was shaped by the loss of both of his parents to cancer. That personal history informed a clear organizational emphasis on early detection of serious disease rather than exclusive reliance on symptom driven care.
From the outset, the business model centered on preventive screening that does not depend on a referral or a specific diagnostic code. The aim was to provide advanced imaging to individuals who may feel well, but who want a clearer understanding of underlying risk.
Over time, Life Imaging FLA has expanded beyond its original site. The organization now operates centers in Deerfield Beach, Orlando, Jupiter, and Miami, with planned expansion toward Jacksonville. This growth reflects sustained demand for consumer accessible imaging in a region with a large adult and older adult population.
Service model and target population
Life Imaging FLA offers two primary categories of service: preventive heart scans and full body screening. The stated target group is adults over 20 years of age. Within that broad segment, many clients have family histories of heart disease or cancer, or a general preference for a proactive approach to health monitoring.
In conventional pathways, advanced imaging is often ordered after symptoms appear or after abnormal findings on basic tests. In contrast, Life Imaging FLA presents imaging as an elective, preventive choice. Clients can schedule appointments directly at any of the company’s Florida locations.
The organization reports that it has screened more than 100,000 individuals. It attributes more than 2,600 life saving outcomes to its heart scans, based on findings that led to timely follow up and intervention. These figures provide an internal measure of impact and scale and support the company’s positioning as an early detection front line for cardiovascular risk.
Heart screening and coronary risk assessment
Heart screening is central to the Life Imaging FLA service profile. The company focuses on detecting early structural and calcific changes that may precede clinical events.
In the wider cardiology field, coronary artery calcium testing has become a valuable tool for risk assessment. The American Heart Association describes coronary artery calcium testing as a form of heart scan that uses imaging to detect calcium deposits in the coronary arteries. The resulting calcium score provides information about plaque burden and helps estimate future heart attack risk and possible arterial blockages.
Life Imaging FLA aligns its heart services with this preventive paradigm. The goal is to identify individuals who may benefit from earlier or more intensive risk factor management. Clients can then review their images and reports with primary care clinicians or cardiologists, who integrate the findings into broader risk reduction plans that may include lifestyle change, pharmacotherapy, or further diagnostic testing.
Full body screening and oncologic context
In addition to heart imaging, Life Imaging FLA provides full body screening. The company frames this as a way to search for small abnormalities that could represent early manifestations of cancer or other serious conditions.
This focus corresponds with long standing public health guidance that emphasizes early detection of malignancy. The US Preventive Services Task Force supports screening for breast, cervical, colorectal, and lung cancers using evidence based protocols and has documented substantial reductions in mortality from these programs. It has also highlighted important evidence gaps, including optimal strategies for adults younger than 50 years, the need to understand and address higher incidence and mortality in Black adults, and the need for more data on adherence to repeated tests over time.
The American Cancer Society recommends annual low dose computed tomography screening for lung cancer in adults aged 50 to 80 years who have a significant smoking history. The Centers for Disease Control and Prevention supports screening for breast, cervical, colorectal, and lung cancers in alignment with recommendations from the US Preventive Services Task Force, and emphasizes that detecting cancer before symptoms appear generally improves treatment options and outcomes.
A modeling study led by National Institutes of Health researchers and published in JAMA Oncology examined breast, cervical, colorectal, lung, and prostate cancers over a 45 year period. The analysis estimated that prevention and screening together accounted for the majority of deaths averted in these five cancers and that treatment advances, while important, contributed a smaller share. The study concluded that approximately eight out of ten deaths averted across these malignancies were linked to prevention and screening efforts.
Life Imaging FLA situates its full body screening within this wider context, presenting early detection as a way to increase the likelihood that disease, if present, is identified at a more treatable stage.
Why missed diagnoses matter in the prevention conversation
Discussions about prevention are often framed around technology and guidelines, but they are also shaped by real human consequences when disease is not identified early. National reporting has increasingly highlighted how delayed or missed diagnoses can alter the course of otherwise treatable illness.
A recent BBC News investigation described the case of Claire O’Shea, a 42-year-old woman whose cancer was repeatedly misattributed to irritable bowel syndrome. Imaging and further evaluation were delayed, and by the time the correct diagnosis was made, the disease had progressed to an advanced and incurable stage. Her story, echoed by many others who felt their concerns were dismissed or overlooked, illustrates how symptom-driven pathways can sometimes fail to surface serious underlying conditions until options are limited.
Stories like this provide important context for why some individuals seek earlier, elective imaging — even when they feel well. They highlight the gap that can exist between the onset of disease and the point at which traditional systems trigger advanced testing. In this environment, preventive screening models aim to reduce reliance on symptoms alone by identifying structural or biological changes earlier in the disease continuum.
Within that broader landscape, Life Imaging FLA’s emphasis on proactive heart and full-body screening reflects a growing desire among adults to better understand risk before illness declares itself clinically. While imaging does not replace longitudinal care or clinical judgment, earlier access to diagnostic information may help reduce the chance that serious disease remains undetected until it becomes far more difficult to treat.
Access, payment structure, and client pathways
A notable characteristic of the Life Imaging FLA model is its focus on individuals who may not qualify for insurance covered imaging but who wish to pursue evaluation on their own. In many health plans, advanced scans are reimbursed primarily when specific signs, symptoms, or lab abnormalities are documented.
Life Imaging FLA offers a self pay pathway. The organization indicates that it has developed a pricing structure that accounts for criteria such as family history, with the goal of maintaining affordability for clients who see preventive screening as a health investment.
After completing scans, clients receive results that can be shared with existing clinicians. In this framework, Life Imaging FLA functions as a diagnostic resource rather than a replacement for ongoing primary or specialty care. The intent is to provide actionable information that can be integrated into long term management strategies.
Positioning within public health and prevention
Heart disease, cancer, and medical errors are identified as leading causes of death in the United States. Against this backdrop, Life Imaging FLA defines its mission in prevention oriented terms. The company seeks to operate at the point where individuals are still asymptomatic but want additional data to guide decisions about lifestyle, monitoring, and potential intervention.
Its messaging emphasizes themes such as health, fitness, longevity, family, wealth, nutrition, holistic medicine, preventive medicine, and early detection. The internal phrase healthy is the new wealthy encapsulates its view that health status is a core form of personal capital. In this framing, investing resources in prevention is positioned alongside more familiar forms of financial planning.
By aligning its focus with evidence based screening movements and long term mortality data, Life Imaging FLA presents itself as part of a broader shift in care from purely reactive responses to an integrated model that includes risk identification and modification earlier in the disease continuum.
Public online feedback in the decision process
Although the primary emphasis of Life Imaging FLA is service delivery, public feedback plays a practical role in how potential clients approach the organization. In contemporary health related decision making, many individuals search for information about facilities, read ratings, and review other people’s experiences before scheduling services.
For a preventive imaging provider, these public signals function as an additional layer of information alongside clinical scope, geographic accessibility, and cost. They help prospective clients understand how the service is structured and how it may fit into their own preventive plans.
In this sense, online feedback is part of the wider informational environment around Life Imaging FLA, even though the core value proposition remains grounded in imaging technology, early detection goals, and alignment with recognized prevention priorities.
Organizational values and operational orientation
Life Imaging FLA articulates a set of values centered on compassion, early detection, and preservation of quality of life. The loss of the founder’s parents to cancer informs an internal commitment to viewing each screening as an opportunity to shift the trajectory of disease.
The company’s stated goals include being recognized as a leading preventive screening provider for heart disease and cancer, maintaining a strong emphasis on the power of prevention, and supporting clients in taking an active role in their health trajectories. The organization describes a focus on measurable performance, close monitoring of year over year and month over month outcomes, and continuous acquisition of skills required to compete effectively in its niche.
The relationship between the organization and its clients is described as symbiotic. Life Imaging FLA provides access to advanced imaging and structured processes, while individuals bring their personal histories, motivations, and readiness to act on the information produced by screening.
Implications for preventive care
The Life Imaging FLA model illustrates how consumer facing imaging services can intersect with established prevention science. Its expansion from a single site in Deerfield Beach to centers in Orlando, Jupiter, and Miami, and planned growth toward Jacksonville, demonstrates that there is substantial interest in preventive screening options outside traditional referral pathways.
For clinicians and health systems, this trend raises important opportunities. External imaging providers can generate data that, when appropriately interpreted, support earlier risk stratification and more individualized prevention plans. For patients, access to elective heart and body scans provides another tool for understanding risk in the context of family history, lifestyle, and existing guideline based screening.
Within a healthcare environment where heart disease, cancer, and medical errors remain major causes of mortality, organizations such as Life Imaging FLA represent one approach to shifting detection earlier in the disease course. Their work sits alongside guideline driven programs, public health campaigns, and ongoing research into optimal screening strategies and adherence.